Skip to main content

A Note on Discrimination Between Carbon Monoxide as a Metabolite of Carbon Tetrachloride and as a Degradation Product of the Biological Material

  • Chapter
Book cover Drug Metabolite Isolation and Determination

Part of the book series: Methodological Surveys in Biochemistry and Analysis ((ANAY,volume 12))

  • 80 Accesses

Abstract

Carbon monoxide has now been identified as a metabolite of a number of foreign compounds, including tetrahalogenomethanes [1]3 trihalogenomethanes [2], trichloroethylene [3] and methylenedioxyphenyl compounds [5]. It is produced as a result of interactions with cytochrome P-450 of the microsomal monooxygenase enzyme system of liver. In several instances, and particularly with CCl4, the metabolic inactivation by cytochrome P-450 results in loss of haem and initiation of lipid peroxidative damage of the microsomal membranes. Both haem degradation and lipid peroxidation are possible sources of CO, and consequently there is an analytical problem in distinguishing between CO produced as a metabolite of the foreign compound and that which arises from degradation of the biological components.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wolf, C.R., Mansuy, D., Nastainczyk, V., Deatchmann, G. & Ullrich, V. (1977)Mol. Pharmacol. 13, 698–705.

    CAS  Google Scholar 

  2. Ahmed, A.E., Kubic, V.L. & Anders, M.W. (1977) Drug Metab. Dispos. 5, 198–204.

    Google Scholar 

  3. Kubic, V.L. & Anders, M.W. (1975) Drug Metab. Dispos. 3, 104–112.

    Google Scholar 

  4. Traylor, P.S., Nastainczyk, W. & Ullrich, V. (1977) in Microsomes and Drug Oxidations (Ullrich, V., et al., eds.) , Pergamon, Oxford, pp. 104–112.

    Google Scholar 

  5. Yu, L.S., Wilkinson, C.F. & Anders, M.W. (1980) Biochem. Pharmacol. 29, 1111–1122.

    Google Scholar 

  6. Ahr, H., King, L.J., Nastainczyk, W. & Albrich, V. (1980) Biochem. Pharmacol. 23, 2855–2861.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this chapter

Cite this chapter

King, L.J. (1983). A Note on Discrimination Between Carbon Monoxide as a Metabolite of Carbon Tetrachloride and as a Degradation Product of the Biological Material. In: Reid, E., Leppard, J.P. (eds) Drug Metabolite Isolation and Determination. Methodological Surveys in Biochemistry and Analysis, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4484-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4484-1_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4486-5

  • Online ISBN: 978-1-4684-4484-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics